Sukish provides strategic Pharma R&D Transfer Negotiation services tailored to the unique needs of the pharmaceutical and biotech sectors. We support clients in negotiating agreements that enable the smooth and mutually beneficial transfer of drug discovery, clinical research, and therapeutic innovations across institutions and commercial partners. The Key Benefits include:
End-to-End Deal Structuring : Guide clients through the negotiation of licensing, joint development, and R&D collaboration agreements.
IP & Patent Strategy Alignment : Ensure intellectual property portfolios are leveraged effectively within the scope of the transfer.
Regulatory-Sensitive Terms : Integrate clauses aligned with FDA/EMA compliance, clinical trial stages, and approval timelines.
Valuation of Pharma IP : Support fair market valuation of molecules, formulations, and associated research data.
Risk Mitigation Planning : Draft terms to manage clinical, technical, and commercial risks in the development pipeline.
Revenue & Royalty Frameworks : Design tiered royalty, milestone, and profit-sharing models tailored to the deal structure.
Cross-Border Negotiation Expertise : Facilitate negotiations involving international partners, IP jurisdictions, and regulatory bodies.
Reviews
There are no reviews yet.